Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT04789044 · Major Extremity Trauma Research Consortium

Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)

What this study is about

The overall objective of this study is to determine the safety of PEG fusion when used with primary repair or reconstruction in patients with an acute upper extremity peripheral nerve injury.

View original scientific description

The overall objective of this study is to determine the safety of PEG fusion when used with primary repair or reconstruction in patients with an acute upper extremity peripheral nerve injury. PEG is safe and effective for extending the half-life of circulating pharmaceutical products, when used in conjunction with a topical hemostatic agent in surgical wounds, and when used as a colon cleanser for endoscopic surgical procedures.

Interventions

DRUG

NTX-001

• PEG fusion is the application of a polyethylene glycol (PEG) using a combination of sequenced reagents to a freshly performed nerve coaptation, or neurorrhaphy, to allow the axonal membranes of the proximal and distal axonal stumps to fuse back together and re-establish full axonal continuity.

Primary outcome measures

Complications or problems that occur with in the first 30 days.

Time frame: Up to 2 years

Complications or problems include surgical site infections, wound dehiscence/breakdown, exposure of nerves and/or their repairs and reconstructions, breakdown of nerve repair or reconstruction, seroma/hematoma requiring an additional procedure to treat, and any other local wound complications related to the zone of nerve injury that require an additional surgical procedure

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Ages 18-80 2. Sustained a complete peripheral nerve injury resulting from upper extremity trauma presenting within 48 hours of injury 3. Involves injury or dysfunction to motor and/or sensory function of the axillary, radial, median, ulnar, or musculocutaneous nerve with injury localized between the proximal humerus and the distal flexion crease of the wrist 4. Involves a "mixed" nerve segment (i.e., involves a location of any of the above specified nerves that can be expected to have both sensory and motor axons present).

Exclusion criteria

  • Patients beginning surgery within hours after injury. 2. Injury to the brachial plexus nerves 3. Injury to the nerves distal to the distal flexion crease of the wrist 4. Injury that involves a distal extension of the parent nerve that is considered sensory only (superficial radial nerve, lateral antebrachial cutaneous nerve, etc.) or the posterior interosseus or anterior interosseus nerve distal to the midpoint of the

Where

  • Baltimore, Maryland
  • Camden, New Jersey
  • Charlotte, North Carolina
  • York, Pennsylvania
  • San Antonio, Texas
  • Richmond, Virginia

Collaborators

United States Department of Defense

Related conditions & keywords

Peripheral Nerve Injuries

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Feb 27, 2026 · Source of record for eligibility and locations

📊
1 of 40 participants interested
3% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Baltimore

Maryland

Location available
RECRUITING

Baltimore

Maryland

Location available
RECRUITING

Camden

New Jersey

Location available
RECRUITING

Charlotte

North Carolina

Location available
RECRUITING

York

Pennsylvania

Location available
View York location page
RECRUITING

San Antonio

Texas

Location available
RECRUITING

Richmond

Virginia

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Heart Attack Trials by City

Browse all heart attack clinical trials in these cities — not just this study.

Looking for Based on the provided information, I cannot determine a primary patient-facing medical condition. The study title mentions "PEG Fusion" which appears to be a treatment technique, and the only condition listed is "DRUG:NTX-001" which is a drug identifier rather than a medical condition. Without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. Treatment in Baltimore?

Join others in Maryland exploring innovative treatment options through clinical research

Based on the provided information, I cannot determine a primary patient-facing medical condition. The study title mentions "PEG Fusion" which appears to be a treatment technique, and the only condition listed is "DRUG:NTX-001" which is a drug identifier rather than a medical condition. Without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. Treatment Options in Baltimore, Maryland

If you're searching for Based on the provided information, I cannot determine a primary patient-facing medical condition. The study title mentions "PEG Fusion" which appears to be a treatment technique, and the only condition listed is "DRUG:NTX-001" which is a drug identifier rather than a medical condition. Without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. treatment in Baltimore, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Baltimore, Camden, Charlotte and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Based on the provided information, I cannot determine a primary patient-facing medical condition. The study title mentions "PEG Fusion" which appears to be a treatment technique, and the only condition listed is "DRUG:NTX-001" which is a drug identifier rather than a medical condition. Without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition.. All study-related care is provided at no cost to participants.

Local Sites
3 locations in Maryland
Now Enrolling
Up to 40 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Based on the provided information, I cannot determine a primary patient-facing medical condition. The study title mentions "PEG Fusion" which appears to be a treatment technique, and the only condition listed is "DRUG:NTX-001" which is a drug identifier rather than a medical condition. Without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition.?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Based on the provided information, I cannot determine a primary patient-facing medical condition. The study title mentions "PEG Fusion" which appears to be a treatment technique, and the only condition listed is "DRUG:NTX-001" which is a drug identifier rather than a medical condition. Without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition.

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Based on the provided information, I cannot determine a primary patient-facing medical condition. The study title mentions "PEG Fusion" which appears to be a treatment technique, and the only condition listed is "DRUG:NTX-001" which is a drug identifier rather than a medical condition. Without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT04789044. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.